WellBeam Raises $10M Series A to Advance EMR Interoperability and Post‑Acute Care Coordination
WellBeam, a Redwood City, California‑based healthcare technology company focused on solving one of the most persistent challenges in modern clinical care — seamless data exchange between acute and post‑acute care providers — has secured a $10 million Series A funding round that is expected to accelerate the company’s mission of driving interoperable workflows, better care coordination and improved patient outcomes across the healthcare continuum.
The funding round, announced in November 2025, was led by Wittington Ventures, a multi‑stage investment platform that backs transformative companies across sectors including healthcare, consumer and commerce. Alongside Wittington Ventures, the round included participation from strategic and institutional investors: F‑Prime, a global venture capital firm focused on healthcare and technology; Advocate Health, one of the nation’s largest nonprofit integrated health systems; and Oncology Ventures, an investment firm specializing in cancer and healthcare innovation.
WellBeam’s Series A financing represents a critical step for the company as it scales its interoperability technology — designed to break down entrenched electronic medical record (EMR) silos that have long challenged care teams’ ability to share and act on clinical data across settings. By enabling acute care providers, physician networks and post‑acute partners such as home health and hospice agencies to communicate and collaborate directly within existing EMR systems, the platform aims to reduce administrative burden, enhance clinical efficiency and improve patient outcomes during key care transitions.
The capital will be used to expand WellBeam’s existing interoperability infrastructure, deepen integrations with EMRs used across the healthcare ecosystem, and grow the company’s team to support product development and customer success as demand grows. Leaders at the company say that seamless data flow between hospitals and post‑acute settings such as skilled nursing facilities remains a “critical and unresolved” challenge for many health systems and physician groups, with implications for unplanned readmissions, patient safety and overall cost of care.
“Healthcare systems are under increasing pressure to deliver high‑quality, cost‑effective care as patients move across care settings,” said Megh Gupta, managing partner at Wittington Ventures. He noted that WellBeam’s connected provider network and EMR‑integrated workflows directly address longstanding interoperability challenges, giving care teams the tools they need to coordinate smoothly across settings and improve outcomes.
WellBeam’s approach centers on embedding streamlined clinical workflows into the user’s existing EMR environment, eliminating reliance on outdated methods such as fax and phone calls that have historically hindered real‑time collaboration. This means clinicians can complete key tasks — from orders and documentation to authorizations and follow‑ups — directly within familiar systems, reducing friction and manual work. Its platform also aims to unlock new revenue opportunities for providers by capturing billable codes and streamlining clinical documentation across transitions of care.
Early customer data reported by the company shows measurable improvements across institutions that have adopted the technology, including significant reductions in unplanned post‑acute care, decreases in manual clinical workflows, and meaningful operational efficiencies that support both quality outcomes and financial performance. These results highlight WellBeam’s potential to deliver what industry leaders call the “triple bottom line” of quality, efficiency and financial impact — a rare combination in healthcare technology deployments.
Advocate Health’s participation as a strategic investor underscores the importance of interoperable solutions in large, complex health systems. Advocate’s backing not only provides financial support but also critical insights into operational needs across thousands of physicians and hundreds of care locations, reinforcing WellBeam’s mission to bridge care settings where data fragmentation has traditionally impeded continuity of care.
The Series A round also follows WellBeam’s ongoing efforts to extend its footprint among acute, ambulatory and post‑acute providers by offering a platform that supports real‑time information sharing and workflow automation. As the company continues to enhance its interoperability core and expand its network of connected providers, its investors believe WellBeam is well‑positioned to influence how data moves through healthcare ecosystems, ultimately enabling better coordinated care and stronger financial performance for clinical organizations of all sizes.
Founded in 2019, WellBeam has steadily evolved its product and partnerships to address clinical team burdens and data exchange gaps that have long limited progress in coordinated care. The newly secured $10 million in Series A funding is expected to help the company execute on its vision of delivering seamless, EMR‑integrated interoperability that supports care teams across the patient journey — from acute settings to post‑acute and beyond.
